NCT04835831View on ClinicalTrials.gov

Interest of APA in Fatty Liver Disease Evaluation of Efficacy and Adherence to an Adapted Physical Activity (APA) Program in Patients With Metabolic Fatty Liver Disease

NACompletedINTERVENTIONAL

Enrollment

115

Participants

Timeline

Start Date

September 15, 2021

Primary Completion Date

June 15, 2022

Study Completion Date

January 9, 2025

Conditions

Non-Alcoholic Fatty Liver Disease (NAFLD

Interventions

OTHER

adapted physical activity + Dietetic advice

adapted physical activity during 24 weeks

Trial Locations (2)

66046

Ch de Perpignan, Perpignan

06000

CHU de Nice, Nice

All Listed Sponsors

lead

Centre Hospitalier Universitaire de Nice

OTHER

NCT04835831 - Interest of APA in Fatty Liver Disease Evaluation of Efficacy and Adherence to an Adapted Physical Activity (APA) Program in Patients With Metabolic Fatty Liver Disease | Biotech Hunter | Biotech Hunter